Open access
1,241
Views
1
CrossRef citations to date
0
Altmetric
Pneumococcal – Letter
Reply letter to “response to article by Johnna Perdrizet et al.” by Gomez and colleagues
Johnna Perdrizeta Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USACorrespondence[email protected]
https://orcid.org/0000-0002-4260-7607View further author information
, https://orcid.org/0000-0002-4260-7607View further author information
Carlos Felipe S. Santanab Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, BrazilView further author information
, Thais Sennab Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, BrazilView further author information
, Rodrigo Fernandes Alexandreb Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, Brazilhttps://orcid.org/0000-0002-1010-276XView further author information
, Rodrigo Sini de Almeidac Medical and Scientific Affairs, Pfizer Inc, Sao Paulo, BrazilView further author information
, Julia Spinardic Medical and Scientific Affairs, Pfizer Inc, Sao Paulo, BrazilView further author information
& Matt Wassermana Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USAhttps://orcid.org/0000-0003-3300-2742View further author information
show all
Article: 1917237
|
Received 23 Mar 2021, Accepted 08 Apr 2021, Published online: 28 Apr 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.